Similar articles for PMID: 31474326

Year	Number of Results
2009	1
2010	1
2011	3
2012	5
2013	12
2014	14
2015	16
2016	14
2017	25
2018	23
2019	21
2020	17
2021	15
2022	22
2023	5
2024	0

1

Prevalence and Clinical Impact of Iron Deficiency in Patients With Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Lessmann L, Wiebe J, Mayr NP, Michel J, Trenkwalder T, Kasel AM, Schunkert H, Kastrati A, Joner M, Husser O, Hengstenberg C. Rheude T, et al. Am J Cardiol. 2019 Nov 1;124(9):1442-1448. doi: 10.1016/j.amjcard.2019.07.051. Epub 2019 Aug 7. Am J Cardiol. 2019. PMID: 31474326

2

Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Michel J, Trenkwalder T, Mayr NP, Kessler T, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O. Rheude T, et al. Int J Cardiol. 2017 Oct 1;244:93-99. doi: 10.1016/j.ijcard.2017.06.024. Epub 2017 Jun 13. Int J Cardiol. 2017. PMID: 28645804

3

Prognostic Impact of Underweight (Body Mass Index <20 kg/m²) in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement (from the German Aortic Valve Registry [GARY]).

Voigtländer L, Twerenbold R, Schäfer U, Conradi L, Balaban Ü, Bekeredjian R, Ensminger S, Walther T, Beckmann A, Frerker C, Bauer T, Hamm C, Möllmann H, Bleiziffer S; GARY Executive Board. Voigtländer L, et al. Am J Cardiol. 2020 Aug 15;129:79-86. doi: 10.1016/j.amjcard.2020.05.002. Epub 2020 May 13. Am J Cardiol. 2020. PMID: 32540167

4

Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.

Nagura F, Kataoka A, Hara M, Kozuma K, Watanabe Y, Nakashima M, Hioki H, Kawashima H, Nara Y, Shirai S, Tada N, Araki M, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Higashimori A, Takagi K, Yamamoto M, Hayashida K; OCEAN-TAVI investigators. Nagura F, et al. Heart Vessels. 2019 Jun;34(6):1031-1039. doi: 10.1007/s00380-018-01329-2. Epub 2019 Jan 1. Heart Vessels. 2019. PMID: 30599060

5

Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis.

Gaglia MA Jr, Lipinski MJ, Torguson R, Gai J, Ben-Dor I, Bernardo NL, Satler LF, Pichard AD, Waksman R. Gaglia MA Jr, et al. Am J Cardiol. 2016 Dec 1;118(11):1692-1697. doi: 10.1016/j.amjcard.2016.08.049. Epub 2016 Aug 30. Am J Cardiol. 2016. PMID: 27666174

6

Thirty-Day Readmissions After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis in New York State.

Hannan EL, Samadashvili Z, Jordan D, Sundt TM 3rd, Stamato NJ, Lahey SJ, Gold JP, Wechsler A, Ashraf MH, Ruiz C, Wilson S, Smith CR. Hannan EL, et al. Circ Cardiovasc Interv. 2015 Aug;8(8):e002744. doi: 10.1161/CIRCINTERVENTIONS.115.002744. Circ Cardiovasc Interv. 2015. PMID: 26227347

7

Outcomes of Transfemoral Transcatheter Aortic Valve Implantation in Patients With Previous Coronary Bypass.

Leshem-Rubinow E, Abramowitz Y, Steinvil A, Ben-Assa E, Chorin E, Shacham Y, Yankelson L, Konigstein M, Keren G, Banai S, Finkelstein A. Leshem-Rubinow E, et al. Am J Cardiol. 2015 Aug 1;116(3):431-5. doi: 10.1016/j.amjcard.2015.04.055. Epub 2015 May 9. Am J Cardiol. 2015. PMID: 26054290

8

Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the IIISAS randomised trial.

Kvaslerud AB, Bardan S, Andresen K, Kløve SF, Fagerland MW, Edvardsen T, Gullestad L, Broch K. Kvaslerud AB, et al. Eur J Heart Fail. 2022 Jul;24(7):1269-1279. doi: 10.1002/ejhf.2557. Epub 2022 Jun 3. Eur J Heart Fail. 2022. PMID: 35579454 Free PMC article. Clinical Trial.

9

The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.

Bouleti C, Chauvet M, Franchineau G, Himbert D, Iung B, Alos B, Brochet E, Urena M, Ghodbane W, Ou P, Provenchere S, Nataf P, Vahanian A. Bouleti C, et al. Eur J Cardiothorac Surg. 2017 Jan;51(1):80-88. doi: 10.1093/ejcts/ezw211. Epub 2016 Aug 30. Eur J Cardiothorac Surg. 2017. PMID: 27582074

10

Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial.

Bardan S, Kvaslerud AB, Andresen K, Kløve SF, Edvardsen T, Gullestad L, Broch K. Bardan S, et al. BMJ Open. 2022 Sep 2;12(9):e059546. doi: 10.1136/bmjopen-2021-059546. BMJ Open. 2022. PMID: 36691165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

158 results

Results by year